Xiaoxue Zhu
Papers
1
Total Citations
22
H-Index
1
About
Xiaoxue Zhu is a pioneering researcher at the intersection of nanobiotechnology and gastrointestinal medicine, whose work is redefining therapeutic strategies for inflammatory bowel disease (IBD). Her most celebrated contribution is the development of a groundbreaking "Microalgae‐Probiotic‐Nanozyme Robot"—a biohybrid microrobot that integrates living microalgae, probiotics, and synthetic nanozymes to actively navigate the gut and alleviate intestinal inflammation. This innovative platform simultaneously targets oxidative stress, restores microbiota dysbiosis, and repairs the intestinal barrier, addressing three core pathological challenges of IBD that conventional therapies fail to resolve. Published in 2025, this work has already garnered 22 citations, reflecting its immediate impact and potential for clinical translation. Zhu’s research uniquely bridges materials science, microbiology, and immunology, offering a paradigm shift from passive drug delivery to active, self-propelled therapeutic systems. Her achievements highlight a rare ability to engineer living and non-living components into a single, intelligent therapeutic robot, positioning her as a rising leader in the field of biohybrid nanomedicine and a promising innovator for next-generation gastrointestinal treatments.
Research Focus
Key Achievements
Top Papers
- 1